MedDataX Logo

The Effects of Patient Features on Opioid Induced End-Tidal CO2

NCT ID: NCT01371903

Last Updated: 2014-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

278 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of a Pharmaceutical Interview at the Initiation of Opioid Treatment for Acute Non-cancer Pain

NCT07049796

Interviews
COMPLETED

The Role of Opioidergic Systems in Breathing Based Analgesia

NCT03419858

Pain
COMPLETED EARLY_PHASE1

CO2 Monitoring Study

NCT02068274

Chronic Pain Hypercapnia Quality of Life
COMPLETED

The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy

NCT03659513

Hypoxia Extracorporeal Membrane Oxygenation Complication
COMPLETED

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

NCT00945919

Chronic Nociceptive Pain Neuropathic Pain Non-cancer Pain
UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use During Medical Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non intubated patients receiving intravenous opioid medications

Exclusion Criteria

* mechanically ventilated patients
* patients with physiologic shock
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Albany Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wayne Triner

Professor Emergency Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Albany Medical Center Emergency Department

Albany, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2792

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department
NCT03257319 COMPLETED PHASE3
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 COMPLETED PHASE3
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
NCT05856136 RECRUITING PHASE4
OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
NCT00271973 COMPLETED PHASE4
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024 COMPLETED NA
Measuring Changes in Acute Pain in the Emergency Department Using Patient Reported Scales
NCT01723137 COMPLETED
Fentanyl Patch Pharmacokinetics in Healthy Adults
NCT02531971 COMPLETED PHASE4
Oxidative Balance in Opioid Therapy
NCT04227223 COMPLETED NA
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00226421 COMPLETED PHASE3
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
NCT04218409 RECRUITING EARLY_PHASE1
Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge Discharge
NCT01402375 COMPLETED PHASE3
Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl
NCT03894800 COMPLETED PHASE4
Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers
NCT00730054 COMPLETED PHASE1/PHASE2
Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients
NCT01591382 COMPLETED PHASE4
Effectiveness and Feasibility of Patient Controlled Analgesia in the ED
NCT01775371 COMPLETED NA
First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers
NCT01975753 COMPLETED PHASE1/PHASE2
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
NCT00305110 COMPLETED PHASE2
PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine
NCT06519045 ACTIVE_NOT_RECRUITING
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 UNKNOWN NA
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 COMPLETED PHASE2/PHASE3
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176121 COMPLETED PHASE4
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 COMPLETED PHASE3
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ACTIVE_NOT_RECRUITING
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 UNKNOWN NA
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 COMPLETED PHASE3